A successful entrepreneur and CEO with more than two decades of leading private and public companies, Ian has successfully led the turnaround, re-capitalization and listing of several businesses, returning them to profit. He holds a Business Education Diploma from the University of Newcastle, and a Licentiateship (LCGI) (NVQ Level 4) from the Royal Navy.

Savvas is Chief Investment Officer at Deepbridge. Prior to joining Deepbridge, Savvas enjoyed a 15 year career in the City, working as an investment banker at JP Morgan, Bear Stearns, Shore Capital, Cantor Fitzgerald, and Panmure Gordon. Savvas was also CEO of telemedicine business Now Healthcare Group.  As a highly acclaimed analyst, Savvas has won multiple awards, most recently in 2015 when Savvas was ranked 2nd overall in the prestigious Reuters Starmine survey, a position he also held in 2014. In the same year, Savvas was also runner-up in the CityAM Analyst of the Year awards. Savvas holds a PhD in psychopharmacology from Nottingham University and a BSc (Hons) degree in pharmacology from Manchester University.

With a wealth of experience in financial services, including institutional fund management within the Lloyd’s of London insurance community, and HNW private client stockbroking at Popes Stockbrokers (now Brewin Dolphin), Kieran has an indepth knowledge of the private capital markets, involving capital raising, investor relations and communication, and is responsible for the fund-raising activities at Deepbridge. Kieran has been a Fellow of the Chartered Institute of Securities and Investments since 2001.

Through his position on the Investment Supervisory Committee, Kieran acts as a conduit between the Executive Team at Deepbridge and the Independent Committee Team, thus ensuring the Independent Committee have access to all information required to assist them in making sound and strategic investment decisions on a timely basis.

Dr, Andrew Round is Investment Director at Deepbridge. Prior to joining Deepbridge, Andy has been an investor in Healthcare and Life Science companies for the past 15 years with Praetura Ventures, Maven Capital Partners and now Deepbridge. Andy has several Healthcare exits under his belt and has managed investments from both EIS and VCT funds as well as public/private funds and balance sheet investments. Andy has also worked as a consultant for companies such as DSM, Sumitomo Chemical, Bayer and Lanxess advising them and assisting them on Mergers and Acquisitions. Andy has also been a Founder in an early-stage Biotech company that raised in excess of £60m and was listed on AiM, using microbes as a drug delivery vehicle.

Ben is Investment Manager within the Life Sciences team at Deepbridge. Prior to this role, Ben had been the managing director of Touchpoint Service and commercial director of Telmenow the healthcare equipment focussed e-commerce platform. Ben has also been chief commercial officer at Now Healthcare Group, a leading telemedicine provider with its Dr Now app.

With a BA (Hons) in Management from the University of Manchester, Ben’s other corporate experience includes being commercial director at Possum, market leaders in the provision, installation and support of many types of electronic assistive technology.

As a highly-regarded investment management professional, with considerable experience of working closely with financial advisers, Anjali provides pro-active support to Deepbridge’s strategic partners across the UK.

With a BSc (Hons) in Business Management from Brunel University, and a Member of the Chartered Institute for Securities and Investment (MCSI), prior to joining Deepbridge Anjali had been an investment manager for the likes of UBS, Close Asset Management and Charles Stanley.

David is a qualified financial professional and technologist with a broad experience having worked accross numerous sectors, including; power generation, ad-tech, medical devices and defence/aerospace.

As Investment Director at Deepbridge, David’s role is to support the commercialisation and growth of a number of Deepbridge’s portfolio companies, whilst also working on a number of future funding opportunities.

David’s previous role as an Investment Executive at the Development Bank of Wales’ Technology Investments team allowed him to lead investment rounds into a number of fast growing technology companies across a variety of sectors, including; space, AgTech,FinTech and Enterprise Software.

David is a Fellow of the Association of Chartered Certified Accountants and holds a distinction in a MSc in Computing, bringing with him a combination of practical skills and experiences from finance and technology for early stage technology companies.

Although based in Wales David works with clients across the UK and is delighted to be playing a role within the early stage technology ecosystem.